A chemogenetic CRISPR knockout screen identifies a ubiquitin-mediated calcineurin-BMP pathway relay in T cell activation
T cell activation is dependent on calcineurin signalling, yet how this pathway integrates with other regulatory systems remains incompletely understood. Here, we exploit the dual pharmacology of FK506, which inhibits calcineurin while also releasing FKBP12-mediated repression of BMP receptors, to dissect signalling crosstalk during T cell responses. A comparative genome-wide CRISPR knockout screen using FK506 and Cyclosporin A revealed that FK506 uniquely engages BMP pathway components and ubiquitin regulatory networks. Functional analyses in Jurkat and primary human T cells showed that FK506 induces BMP receptor-dependent activation of SMAD1/5/8 and triggers a rapid remodelling of K48- and K29-linked ubiquitin chains. Proteomics further demonstrated selective ubiquitination of immune signalling proteins and ubiquitin regulators, linking BMP pathway activation to proteasome-dependent turnover and non-proteolytic ubiquitin signalling. In primary T cells, BMP receptor signalling enhance calcineurin-driven activation, while changes in ubiquitin conjugation modulate this response, thereby establishing an integrated calcineurin-BMP-ubiquitin relay. Together, our results uncover a context-dependent signalling axis in which BMP activation and ubiquitin dynamics fine-tune calcineurin-mediated T cell signalling.